Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for cephalosporin
Perform Another (Advanced) Search
Related Words: cephalosporin
21 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
Displaying results 1—20
Next > Last »
1. Study Posting (799) Trial #156976, *Healthy Patient Studies, Boston, MA ...of Ceftriaxone in Subjects with ALS Ceftriaxone Study Rationale Ceftriaxone is a semisynthetic, third generation cephalosporin. Cephalosporins are beta-lactam antibiotics approved by the FDA for the treatment of infections such as ...View Page
2. Study Posting (799) Trial #163139, Amyotrophic Lateral Sclerosis (ALS), Boston, MA ...of Ceftriaxone in Subjects with ALS Ceftriaxone Study Rationale Ceftriaxone is a semisynthetic, third generation cephalosporin. Cephalosporins are beta-lactam antibiotics approved by the FDA for the treatment of infections such as ...View Page
3. Study Posting (799) Trial #163131, Amyotrophic Lateral Sclerosis (ALS), Boston, MA ...of Ceftriaxone in Subjects with ALS Ceftriaxone Study Rationale Ceftriaxone is a semisynthetic, third generation cephalosporin. Cephalosporins are beta-lactam antibiotics approved by the FDA for the treatment of infections such as ...View Page
4. Study Posting (799) Trial #156966, Amyotrophic Lateral Sclerosis (ALS), Boston, MA ...of Ceftriaxone in Subjects with ALS Ceftriaxone Study Rationale Ceftriaxone is a semisynthetic, third generation cephalosporin. Cephalosporins are beta-lactam antibiotics approved by the FDA for the treatment of infections such as ...View Page
5. Newly Approved Drug Therapies (720) Spectracef, TAP Pharmaceuticals, ...Pharmaceuticals Approval Status: Approved August 2001 Treatment Area: Bacterial infections General Information Spectracef, a new cephalosporin antibiotic, has been approved in 400 mg tablet formulation for the treatment of acute exacerbations ......Nausea • Vaginal moniliasis • Headache • Dyspepia • Abdominal pain • Vomiting Mechanism of Action Cefditoren pivoxil is a cephalosporin with antibacterial activity against gram-positive and gram-negative bacteria. It has shown effectiveness against ...View Page
6. Study Posting (5175) Trial #155009, Urinary Tract Infections, Fountain Valley, CA ...infection Exclusion Criteria • History of serious allergy, hypersensitivity, or any serious reaction to Carbapenem or Cephalosporin antibiotics. Kristi Maya, Site Director Novellus Research Sites, Inc. 11160 Warner Avenue, Suite 109 Fountain ...View Page
7. Newly Approved Drug Therapies (362) Bactroban Cream, SmithKline Beecham, ...In two randomized, double-blind clinical trials, Bactroban Cream demonstrated equivalent efficacy to the oral cephalosporin antibiotic Keflex. Clinical efficacy rates at follow-up were 96.1% for Bactroban Cream and ...View Page
8. Study Posting (5359) Trial #155051, Urinary Tract Infections, West Reading, PA ...Exclusion Criteria: • Greater than one dose of antibiotics administered prior to study enrollment. • Allergy to cephalosporin or carbapenem antibiotics. • Presence of concurrent infection requiring antibiotics other than the study drugs. • Complete ...View Page
9. CenterWatch Clinical Industry Provider Profile(2913), Almac Clinical Services, Audubon, PA ...Packaging Services Almac Clinical Services have specialised dedicated facilities for the packaging of penicillins and cephalosporins, it is also licensed to package controlled scheduled II to IV drug products. Almac Clinical ...View Page
10. CenterWatch: New Medical Therapies in Disease Category (372), Vaccines ...2004 Basilea Pharmaceutica AG reported positive results from a phase II trial investigating BAL5788 , a cephalosporin antibiotic for the treatment of complicated skin and skin structure infections (cSSSI). Results showed that ......the first days of treatment. In addition, the safety of BAL5788 was similar to other cephalosporins, with mild to moderate nausea/vomiting being the most frequent side effect observed. The study ...View Page
11. CenterWatch: New Medical Therapies in Disease Category (167), Pneumonia ...Chemical Industries issued positive results of a phase I trial of PPI-0903 , its investigational cephalosporin antibiotic for Gram-positive soft complicated skin and skin-structure infections, and hospital- and community ...View Page
12. CenterWatch: New Medical Therapies in Disease Category (79), Hepatitis ...Chemical Industries issued positive results of a phase I trial of PPI-0903 , its investigational cephalosporin antibiotic for Gram-positive soft complicated skin and skin-structure infections, and hospital- and community ...View Page
13. CenterWatch: New Medical Therapies in Disease Category (177), Skin Infections/Disorders ...Chemical Industries issued positive results of a phase I trial of PPI-0903 , its investigational cephalosporin antibiotic for Gram-positive soft complicated skin and skin-structure infections, and hospital- and community ......2004 Basilea Pharmaceutica AG reported positive results from a phase II trial investigating BAL5788 , a cephalosporin antibiotic for the treatment of complicated skin and skin structure infections (cSSSI). Results showed that ...View Page
14. Newly Approved Drug Therapies (353) Omnicef, Warner-Lambert, ...gastrointestinal tract. Omnicef should not be used in patients with a known allergy to the cephalosporin class of antibiotics. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical Information LLC ...View Page
15. Newly Approved Drug Therapies (597) Tequin, Bristol-Myers Squibb, ...from other antibiotics, thereby making it useful for infections that will not respond to penicillin, cephalosporins, macrolides, aminoglycosides, or tetrocyclines. Its antibacterial properties stem from an inhibition of DNA gyrase (an ...View Page
16. Newly Approved Drug Therapies (585) Synercid I.V., Rhone Poulenc Rorer, ...was suspected or confirmed methicillin-resistant staphylococcus or if the patient was allergic to penicillins, cephalosporins or carbapenems. Study JRV 304 enrolled 450 patients (n = 229 Synercid; n= 221 Comparator) and ...View Page
17. Newly Approved Drug Therapies (626) Cefazolin and Dextrose USP, B Braun Medical, ...therapies. Transient hepatitis and cholestatic jaundice are also uncommon side effects associated with penicillin and cephalosporins. Other rare side effects include genital and anal pruritis and rare instances of phlebitis at ......of injection. Cefazolin and Dextrose injection is contraindicated for patients: • with known allergies to the cephalosporin group of antibiotics • with hypersensitivity to corn products • currently taking probenecid Serious or fatal hypersensitivy ...View Page
18. Newly Approved Drug Therapies (750) Invanz, Merck, ...carbapenem related to a class of antibiotics known as beta-lactams, which includes penicillins and cephalosporins. Invanz works by blocking the formation of bacterial cell walls, thereby causing cell death. Additional ...View Page
19. Clinical Trial Results by Drug Names ...b.i.d. = twice daily. 1 The following Class Terms were identified as antibiotics: Penicillins, Cephalosporins, Macrolides, Fluoroquinolones, “Septra DS” and Tetracyclines. Consumption of at least one dose of the above ...View Page
20. Clinical Trial Results by Drug Names ...first study drug intake 2 The following Class Terms were assumed to be antibiotics: Penicillins, Cephalosporins, Macrolides, Fluoroquinolones, “Septra DS” and Tetracyclines. Consumption of at least one dose of the above ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.